Your browser doesn't support javascript.
loading
Future directions in preclinical and translational cancer neuroscience research.
Demir, Ihsan Ekin; Mota Reyes, Carmen; Alrawashdeh, Wasfi; Ceyhan, Güralp O; Deborde, Sylvie; Friess, Helmut; Görgülü, Kivanç; Istvanffy, Rouzanna; Jungwirth, David; Kuner, Rohini; Maryanovich, Maria; Na'ara, Shorook; Renders, Simon; Saloman, Jami L; Scheff, Nicole N; Steenfadt, Hendrik; Stupakov, Pavel; Thiel, Vera; Verma, Divij; Yilmaz, Bengi Su; White, Ruth A; Wang, Timothy C; Wong, Richard J; Frenette, Paul S; Gil, Ziv; Davis, Brian M.
Afiliação
  • Demir IE; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany. ekin.demir@tum.de.
  • Mota Reyes C; Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey. ekin.demir@tum.de.
  • Alrawashdeh W; German Cancer Consortium, Partner Site Munich, Munich, Germany. ekin.demir@tum.de.
  • Ceyhan GO; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany. ekin.demir@tum.de.
  • Deborde S; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Friess H; German Cancer Consortium, Partner Site Munich, Munich, Germany.
  • Görgülü K; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Istvanffy R; Department of HPB and Transplant Surgery, The Freeman Hospital, Newcastle upon Tyne, UK.
  • Jungwirth D; Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Kuner R; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Maryanovich M; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Na'ara S; German Cancer Consortium, Partner Site Munich, Munich, Germany.
  • Renders S; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Saloman JL; Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Scheff NN; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Steenfadt H; German Cancer Consortium, Partner Site Munich, Munich, Germany.
  • Stupakov P; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Thiel V; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Verma D; German Cancer Consortium, Partner Site Munich, Munich, Germany.
  • Yilmaz BS; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • White RA; Department of Molecular Pharmacology, Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
  • Wang TC; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Wong RJ; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Frenette PS; Department of Otolaryngology, Head and Neck Surgery, and the Laboratory for Applied Cancer Research, Rappaport Institute of Medicine and Research, The Technion, Israel Institute of Technology, Haifa, Israel.
  • Gil Z; Head and Neck Center, Rambam Healthcare Campus, Haifa, Israel.
  • Davis BM; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.
Nat Cancer ; 1: 1027-1031, 2021 11.
Article em En | MEDLINE | ID: mdl-34327335
ABSTRACT
Recent advances in cancer neuroscience necessitate the systematic analysis of neural influences in cancer as potential therapeutic targets in oncology. Here, we outline recommendations for future preclinical and translational research in this field.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neurociências / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neurociências / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article